Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-07-30
1999-11-30
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514616, 564153, 564154, 435212, 4241841, 730868, A61K 3800
Patent
active
059943122
ABSTRACT:
Compounds of general formula (I): ##STR1## have utility as inhibitors of matrix metalloproteinases and TNF.
REFERENCES:
patent: 4146611 (1979-03-01), Ondetti et al.
patent: 4235885 (1980-11-01), Sundeen et al.
patent: 4263293 (1981-04-01), Sundeen et al.
patent: 4382081 (1983-05-01), Sundeen et al.
patent: 4511504 (1985-04-01), McCullagh et al.
patent: 5387610 (1995-02-01), Gray et al.
patent: 5455262 (1995-10-01), Schwartz et al.
Fournie-Zaluski et al., Eur. J. Biochem. vol. 139, 267, 1984.
Dayhoff et al., Atlas of Protein Sequence and Structure, vol. 5, Dayhoff (ed.), 1975.
Fournie-Zaluski, M. et al. (1984) "Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme". Eur. J. Biochem. 139: 267-274.
Blumberg, S., Tauber, Z. (1983) "Inhibition of metalloendopeptidases by 2-mercaptoacetyl-dipeptides". Eur. J. Biochem. 136: 151-154.
Dayhoff, M.O. et al. (1992) Atlas of Protein Sequence and Structure, vol. 5. National Biomedical Research Foundation.
Baxter Andrew Douglas
Montana John
Owen David Alan
Phillipson Neil
Watson Robert John
Celsa Bennett
Darwin Discovery Ltd.
LandOfFree
Peptidyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672663